Top Pharmaceutical Companies in Seattle, WA (20)
Who We Are Chewy is where pet parents find everything they need for life with pets, from food to fun to pharmacy. We make pet care easier, more informed, and more joyful through fast, reliable delivery and award-winning 24/7 Customer Care, including access to pet health support when it’s needed. Founded in 2011, Chewy combines the convenience of online shopping with...
Chewy's Top Stability & Growth Strengths
Resilient & Sustainable Growth: Revenue has risen at a steady mid- to high-single-digit pace—FY2025 grew 8.3% on a normalized basis, with FY2026 Q1 and Q2 up 7.7% and 7.3% respectively, alongside 3.8% active-customer growth. Management also raised its FY2026 net sales outlook, pointing to continued expansion.
Customer Loyalty & Retention: Autoship sales increased 9.3% in Q2 FY2026 to about $2.82 billion and represented 84.6% of total sales, supporting predictable, repeat purchasing. Sales per active customer also edged up to $602, indicating deepening engagement.
Profitability: Adjusted EBITDA climbed 23.7% in Q2 FY2026 to $226.7 million with a 6.8% margin, and net income rose year over year. These gains indicate improving operating earnings alongside growth.
Our purpose ensures that patients remain at the center of all we do. We live our purpose by sourcing the best science in the world; partnering with others in the healthcare system to improve access to our medicines; using digital technologies to enhance our drug discovery and development, as well as patient outcomes; and leading the conversation to advocate for...
Pfizer's Top Stability & Growth Strengths
Product Line Growth: Newer and acquired medicines grew 18% operationally in Q2 2026, while revenue excluding Comirnaty and Paxlovid rose 5% operationally in the same period. Excluding COVID products, 2025 revenue also increased 6% operationally, supported by growth in products such as Eliquis and Padcev.
Cost & Operational Efficiency: Management is pursuing additional savings to improve operational efficiency and support profitability. These cost-control efforts are intended to help the business transition away from pandemic-driven sales while supporting margins.
Innovation-Driven Growth: Investment in future growth includes $10.4 billion in internal R&D during 2025 and ongoing development in oncology and obesity. A broad pipeline and recent acquisitions are intended to offset declining COVID-19 sales and patent expirations if programs succeed.
The District Council of Madison Inc., Society of St. Vincent de Paul is a Catholic nonprofit organization based in Madison, Wisconsin. It serves neighbors in need by providing essential resources, including food distribution, charitable pharmacy services, housing support, and financial assistance. These programs are funded by a network of thrift stores, focusing on empowering individuals and families facing hardship to...
Located in Redmond WA, founded in 2014, Systimmune Inc. is a bio-pharmaceutical company focused on the treatment of cancer through developing novel therapeutic bi-specific, and tri-specific antibodies, as well as antibody-drug conjugates (ADC's). Our objective is to create biologics that work through systematic intervention on the solid tumor micro-environment, to either directly attack the tumor and/or to activate the immune...
Dendreon is a commercial-stage biopharmaceutical company and pioneer in the development of immunotherapy. Dendreon’s flagship product, PROVENGE (sipuleucel-T), was the first FDA-approved immunotherapy made from a patient’s own immune cells. More than 40,000 men with advanced prostate cancer have been prescribed PROVENGE in the U.S. since 2010. Dendreon also is evaluating the use of PROVENGE in early-stage prostate cancer, with...
Booster Fuels, Inc. provides an app-based, on-demand mobile fuel delivery service, offering on-site gasoline, diesel, and renewable fuel options directly to corporate fleets and office parking lots. Using technology and 'Smart Tankers,' the company improves operational efficiency, supports the decarbonization of last-mile delivery, and eliminates the need for inefficient trips to gas stations for businesses and commuters.
The National MS Society is a non-profit organization dedicated to curing multiple sclerosis while empowering people affected by the disease to live their best lives through research, education, and support.
Omeros is a Seattle-based commercial-stage biopharmaceutical company that discovers, develops, and commercializes first-in-class small-molecule and protein therapeutics for large-market and orphan indications. Its programs focus on complement-mediated diseases, inflammation, cancers, and addictive or compulsive disorders. The company’s pipeline includes FDA-approved YARTEMLEA, the investigational MASP-2 inhibitor OMS1029, OMS527 in clinical development, and a growing portfolio of molecular and cellular oncology programs.
LeonaBio is dedicated to the development of novel therapeutics for diseases with high unmet needs, including treatment-resistant metastatic breast cancer and amyotrophic lateral sclerosis (ALS), with the goal of improving patient’s lives.
Ascensus Specialties is a specialty-chemicals manufacturer and supplier serving life sciences, pharmaceutical, microelectronics, and other specialty markets. Its portfolio includes borohydrides, boranes, specialty alcoholates, reactive and alkali metals, CVD/ALD precursors, high-purity APIs, and cGMP materials. The company operates production facilities in the United States and the United Kingdom and provides research and development, scale-up, quality, and application support to customers...
Resolve Therapeutics is a biotechnology company developing an exciting new biologic compound for the treatment of lupus that inhibits a key upstream step in the interferon cascade. The company is based on technology and compounds exclusively licensed from the University of Washington. The company will develop these compounds through early clinical testing and partner with a pharmaceutical company for late...
CarepathRx is transforming pharmacy care delivery for health systems and hospitals, delivering improved patient outcomes that drive clinical, quality and financial results. CarepathRx provides the industry’s most comprehensive hospital pharmacy care delivery model, providing support across the patient’s complete healthcare journey—across multiple care settings, from hospital to home, no matter the patient acuity level. We take an enterprise approach to pharmacy...
Novo Nordisk is a leading global healthcare company, founded in 1923 and headquartered in Denmark. Our purpose is to drive change to defeat diabetes and other serious chronic diseases such as obesity and rare blood and endocrine disorders. We do so by pioneering scientific breakthroughs, expanding access to our medicines, and working to prevent and ultimately cure disease. We are powered...
Novo Nordisk's Top Stability & Growth Strengths
Strong Market Position & Advantage: Novo Nordisk is characterized as a global leader in GLP‑1–based diabetes and obesity care, anchored by clinically differentiated products like Wegovy and a broad GLP‑1 portfolio. While shares fluctuate by geography, disclosures and independent analyses continue to frame the company as a category leader.
Innovation-Driven Growth: Cardiovascular outcomes data supporting Wegovy’s label expansion and the first approved oral GLP‑1 for chronic weight management, together with late‑stage assets (e.g., amycretin/zenagamtide, CagriSema), strengthen adoption arguments and extend the franchise.
Market Expansion: U.S. launch momentum for the Wegovy pill, EU approval, and planned international rollouts in 2026 are broadening access and the addressable market. Significant capacity additions, including acquired fill‑finish sites and new investments, are intended to support higher volumes across regions.
Navigating Cancer is the leading digital health solution for oncology. We focus on improving the patient experience, delivering more effective care management, and enabling oncology care innovation.
Christensen, Inc. is a privately held, mid-market fuel, propane, and lubricants distributor operating across the western United States. Founded in 1935, the family-owned and operated company is a leader in distribution across the Pacific Northwest, serving over 10,000 retail fuels, commercial, industrial, and fleet card customers with an innovative suite of products and services.
Umoja is developing a new approach to cancer therapy that retools a patient’s immune system in vivo, enhancing the body’s natural capacity to fight cancer. We envision a world where all patients with cancer have access to the most advanced immunotherapies and are free from the burdens of traditional cancer therapies
We’re designing a better way to deliver and pay for health while engaging and guiding a community of members to live their best health. As a national, team-based medical group with a focus on wellbeing and prevention that extends beyond traditional sick care, we deliver Primary Health. An entirely new model of health, Primary Health is driven by an interdisciplinary...
By unlocking skin biology and applying advanced engineering and software, via its patented microarray patch (MAP), Panther is delivering a comprehensive pipeline of shelf-stable treatments directly to consumers globally. Panther is reshaping healthcare with its compelling end-to-end user experience, and is making its platform available to skincare, pharma, biotech and other partners.
Aurion Biotech, Inc. is a clinical-stage biotechnology company focused on restoring vision through regenerative cell therapies. Founded in 2021 with offices in Seattle, Boston and Tokyo, Aurion develops AURN001, a cultured corneal endothelial cell therapy to treat corneal edema from endothelial dysfunction. The company has advanced clinical programs, regulatory designations, and commercial activity in Japan, aiming to scale donor-cell culture...
